Benuvia Operations, LLC.
Richard Scott Warlick has over 30 years of experience in manufacturing and leadership roles. Richard Scott most recently served as the Vice President of Manufacturing at Benuvia Manufacturing. Prior to that, they held the same role at Insys Therapeutics, Inc. where they were also the General Manager of the Round Rock site. Richard Scott has also worked as a Senior Director of Manufacturing at Mylan and as a Plant Manager at Mallinckrodt Pharmaceuticals. Earlier in their career, they held various roles at Tyco Healthcare Mallinckrodt, Tyco Healthcare Mallinckrodt, Mallinckrodt Inc, Day & Zimmermann, and Champion Paper. Richard Scott has a strong track record of meeting financial, quality, and customer service targets, as well as implementing successful capital investments and improvement projects.
Richard Scott Warlick has a Bachelor of Science degree in Chemical Engineering from North Carolina State University, which they obtained from 1983 to 1987. Richard Scott also holds a Master of Business Administration (MBA) degree in Business from Duke University - The Fuqua School of Business, which they earned from 2000 to 2001. Richard Scott has an additional certification as a Six Sigma Blackbelt from Covidien, although the specific date of completion is not provided.
Benuvia Operations, LLC.
Benuvia Manufacturing is a leading developer and manufacturer of high-purity, pharmaceutical cannabinoid ingredients and products. We offer a comprehensive suite of solutions for pharmaceutical, biotechnology, and consumer product companies to achieve their development and commercial needs. We have over 100,000 square feet of state-of-the-art research, development and manufacturing space across two cGMP facilities in Chandler, Arizona and Round Rock, Texas. We began manufacturing pharmaceutical grade cGMP pure quality cannabidiol (CBD) in 2009 and our Round Rock facility has produced CBD since 2014 (DMF 32552). Today, Round Rock is the only CBD active pharmaceutical ingredient (API) contract manufacturing site in the U.S. producing an FDA approved cannabinoid drug (SYNDROS®). Our facilities are DEA and FDA registered cGMP production sites and are fully regulated and compliant with all DEA, EPA, and OSHA requirements. Further information is available at www.benuviamanufacturing.com.